Last updated: 11/03/2018 10:28:41

Hospital-based surveillance to collect prospective data to estimate the disease burden of severe RV GE in Sweden

GSK study ID
109551
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: A Hospital-based surveillance to collect prospective data to estimate the disease burden of severe RV GE, its complications and diversity of co-circulating rotavirus strains in children < 5 years of age in Sweden
Trial description: This study aims to estimate the burden of RV GE. The study will focus on children hospitalized for severe RV GE, Children acquiring RV GE in the hospital and the household contacts of children hospitalized with RV GE. It is expected to enrol 500-600 subjects in the study. The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep 2007.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

To estimate the incidence of severe rotavirus gastroenteritis (RV GE) and its associated complications in children < 5 years of age.

Timeframe: not applicable

Secondary outcomes:

To determine the gender, age of onset, severity of symptoms and underlying medical conditions in community and nosocomially acquired rotavirus infections

Timeframe: not applicable

To check the incidence of RV antigenemia and viremia associated with severe RV GE and relate this to clinical symptoms and rate of complications in population under surveillance.

Timeframe: not applicable

To estimate the incidence of liver involvement associated with RV GE and relate this to clinical symptoms in the population under surveillance.

Timeframe: not applicable

To explore the possible role of anti-secretory factor in children with RV GE and relate this to clinical symptoms and rate of complications under surveillance.

Timeframe: not applicable

To genotype the isolated rotavirus strains and evaluate a possible correlation to evolved antigenemia, liver involvement and complications in both nosocomially and community-acquired cases with infection of different strain

Timeframe: not applicable

Interventions:
  • Procedure/surgery: Blood sample collection
  • Enrollment:
    642
    Primary completion date:
    Not applicable
    Observational study model:
    Case-Only
    Time perspective:
    Prospective
    Clinical publications:
    Not applicable
    Medical condition
    Rotavirus gastroenteritis
    Product
    SB444563
    Collaborators
    Not applicable
    Study date(s)
    October 2007 to October 2008
    Type
    Observational
    Phase
    Not applicable

    Participation criteria

    Sex
    Female & Male
    Age
    Not applicable N/A - 5 years
    Accepts healthy volunteers
    No
    • Written informed consent obtained from parent or guardian
    • A male/ female child aged less than 5 years. On the day of fifth birthday the subject is not eligible for participation
    • All children in the neonatal wards.

    Trial location(s)

    This study does not involve prospective enrollment of participants.

    Study documents

    No study documents available.

    Results overview

    No study documents available

    Recruitment status
    Study complete
    Actual primary completion date
    Not applicable
    Actual study completion date
    2008-14-10

    Plain language summaries

    Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

    Additional information about the trial

    Not applicable
    Participate in clinical trial
    Access to clinical trial data by researchers
    Visit website